ImmuCell Corp. (ICCC)
9.96
+0.08
(+0.81%)
USD |
NASDAQ |
May 21, 16:00
9.96
0.00 (0.00%)
After-Hours: 19:59
ImmuCell EPS Diluted (Quarterly) : 0.2146 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Amgen, Inc. | 3.344 |
| Savara, Inc. | -0.1472 |
| Biogen, Inc. | 2.153 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.942M |
| Revenue (Quarterly) | 10.36M |
| Total Expenses (Quarterly) | 8.416M |
| Enterprise Value | 95.35M |
| Gross Profit Margin (Quarterly) | 44.97% |
| Profit Margin (Quarterly) | 18.75% |
| Earnings Yield | -0.60% |
| Operating Earnings Yield | 2.78% |
| Normalized Earnings Yield | 1.468 |